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Abstract: β-glucans have been shown to stimulate the immune system in several animal species.
The aim of this study was to evaluate the immune stimulation capacity of a fully formulated diet with
β-1,3-1,6-glucans in cats, by assessing the rabies antibody titer after vaccination. Thirty-five healthy
cats were recruited. The cats were placed into two groups and fed a standard diet in accordance with
body weight. One group had the β-glucans incorporated into the diet; the other group served as
the control group. After two weeks of dietary adjustment; the rabies vaccine (Imrab® 3 TF; Merial)
was administered on days 0 and 21. Blood samples were taken on days 0, 21, and 42. Titers were
determined with the rapid fluorescent foci inhibition test (RFFIT). Titers at days 21 and 42 were
compared between the two groups in a linear mixed effects model. This study showed that the
animals receiving the non-supplemented feed had higher post-vaccination rabies antibody titers.
This indicates that, in contrast to other animal species, the β-glucan supplemented diet did not have
the expected positive effect on the rabies antibody titers in cats.
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1. Introduction
Prebiotics are food ingredients that exert beneficial effects by altering the metabolism in the
intestinal tract [1]. β-1,3-1,6-glucans, derived from the yeast cell wall of Saccharomyces cerevisiae fall
into this category. When extracted from the cell wall of fungi, these polysaccharides can also work as
immunomodulators, by boosting the host’s immune response to antigens in many immuno-therapies [2].
β-glucans have important effects on the immune response. Working through the gut-associated
lymphoid tissue (GALT), β-glucans will bind to the transmembrane protein receptors, TLR2/TLR6
(Toll-like receptors), and dectin-1 on dendritic cells, follicular dendritic cells, macrophages, and even
B-cells [3,4]. β-1,3-1,6-glucans enhance innate immune cellular abundance and function. Through
the primary stimulus of β-1,3-1,6-glucans, there will be an increased abundance of antigen-specific
lymphocytes that result in an increased innate immune response, as well as an increase in humoral and
cellular immune response after vaccination [5,6].
Previous studies in dogs [7], mice [8], and pigs [9,10] have demonstrated that β-1,3-1,6-glucans
produce an increase in the immunological response to rabies vaccination. There are no such data
available for cats, therefore, we investigated the effect of β-1,3-1,6-glucans, added to a balanced cat
diet, on rabies antibody titers following rabies vaccination.
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2. Materials and Methods
2.1. Animals
The animal trial was approved by the RUSVM IACUC under number 19.05.18.
Thirty-six cats were recruited from owners, mainly veterinary students, who signed an informed
consent document. Cats underwent a health check before inclusion and were housed with their owners.
The exclusion criteria were as follows: kittens younger than 3 months, visibly old cats/cats older than
10 years, cats with poor body condition, and seropositive rabies antibody tested cats. Cats were to be
housed inside for the entire study to increase control over the diet. One cat was withdrawn from the
study at the owner’s request.
2.2. Study Design
This was an owner- and investigator-blinded study. The vaccination date was taken as day 0.
On day 21, a 1 mL blood sample was collected for determination of the presence of rabies antibodies.
The BioPro ELISA test was used as the initial screening test (day 21 sample) to demonstrate that
the animals were serologically negative for rabies antibodies. The BioPro ELISA test was executed
according to the instructions of the manufacturer [11]. Cats’ age, sex, and weight were also determined
on day-21. Prior to day 14, the rabies antibody negative animals were allocated to two groups. Subjects
in Group A were given a diet without β-1,3-1,6-glucans (control group) and subjects in Group B were
given the same diet supplemented with β-1,3-1,6-glucans (test group). The cats were assigned to
a group based on a similar distribution of age and sex. The change in diet for both groups began
fourteen days before vaccination. On day 0, a 3 mL blood sample was taken for baseline rabies virus
neutralizing antibody (RVNA) titers, after which the animals were vaccinated with rabies vaccine
(Imrab® 3 TF, Merial, Lyon, France). All blood samples were refrigerated for 24 h, then centrifuged at
2500 rpm for 10 min, after which serum was collected, placed into pre-labeled tubes, and stored at
−80 ◦C. On day 21, a new 3 mL blood sample was taken for RVNA titer determination, after which the
animals received a booster vaccination to increase the titers, to better see an immunological response.
The trial ended on day 42 with a final 3 mL blood draw for endpoint RVNA titers. RVNA titers in sera
at days 0, 21 and 42 were determined by the rapid fluorescent focus inhibition test (RFFIT), performed
at the Kansas State University Rabies Laboratory [12].
2.3. Statistical Analysis
We used R [13] and the lme4 package [14] to perform a linear mixed effects analysis of the
relationship between post-vaccination RVNA titers and diet. As fixed effects, we entered diet (group A
vs. group B) and time (days 21 and 42) into the model. As random effects, we had intercepts for subjects.
A visual inspection of residual plots did not reveal any obvious deviations from homoscedasticity or
normality. p-Values were obtained by likelihood ratio tests of the full model with the effect in question
against the model without the effect in question.
3. Results
Thirty-six cats were enrolled in this study. Thirty-five cats were screened at day 21 with the
BioPro ELISA Rabies AB+ Kit; one cat was withdrawn from the trial prior to initial ELISA test at
the owner’s request. Group A was comprised of 18 cats (9 males and 9 females), while Group B
contained 17 cats (9 males and 8 females), as shown in Table 1. The average weight for Groups A and B
were 3.75 kg and 3.72 kg, respectively. The average ages of Groups A and B were 13.2 months and
14.2 months, respectively.
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Table 1. Epidemiological data based on age and sex.
Group A (Placebo) Group B (Test)
Sex
Male 9 (50%) 9 (53%)
Female 9 (50%) 8 (47%)
Age in months
4–11 6 (33%) 6 (35%)
12–23 8 (44%) 7 (41%)
24–35 3 (17%) 3 (18%)
36+ 1 (6%) 1 (6%)
All 35 of the cats tested negative for rabies antibodies, and thus all were eligible for the study.
RVNA titer results taken from sera at day 0 showed that all cats had titers ≤0.1 IU/mL. The RVNA
levels ranged from 13.10–131 IU/mL in group A, and from 3.3–131 IU/mL in group B. The geometric
mean concentration (± standard error) at day 21 was 15.5 ± 2.7 IU/mL for group A and 6.6 ± 2.9 IU/mL
for group B. The geometric mean concentration at day 42 was 36.6 ± 1.9 IU/mL for group A and
23.5 ± 2.4 IU/mL for group B. Figure 1 shows the log-transformed RVNA levels by diet group and
time. The interaction between diet and time was not statistically significant (χ2 (1) = 1.50, p = 0.22).
Diet affected RVNA levels (χ2 (1) = 6.24, p = 0.012), with levels of cats in Group B lower by an
estimated 1.9 IU/mL ± 1.3. In an exploratory analysis, the effect of sex was not statistically significant
(χ2 (1) = 1.09, p = 0.30). All cats (irrespective of diet) showed an adequate serological response to
rabies vaccine.
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Figure 1. Rabies antibody levels (mean ± standard error) determined by the rapid fluorescent foci
inhibition test (RFFIT) at 0, 21 and 42 days after rabies vaccination in previously-unvaccinated cats fed
a control diet (Group A) or an identical diet supplemented with β-1,3-1,6-glucans (Group B), for 14
days prior to vaccination.
4. Discussion
Studies in dogs [7], mice [8], pigs [9,10], horses [15] and various other species, including fish [16,17]
and invertebrates [18], have demonstrated that β-1,3-1,6-glucans, derived from the yeast cell wall of
Saccharomyces cerevisiae, produce an increase in the immunological response to foreign antigens. In
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our study, although both groups of cats developed an adequate neutralizing antibody response to a
primary and booster injection of the rabies vaccine, the response was lower in cats that were fed a diet
supplemented with β-1,3-1,6-glucans, compared with cats that were fed an un-supplemented diet,
contrary to what was seen in other species.
A major pathway through which β-1,3-1,6-glucans stimulate and prime the immune system is
through the dectin-1 surface protein in conjunction with TLR 2/TLR 6. This pathway has been shown
to cause a change in CD45+, CD8+, and CD4+ T-cells, in the mesenteric lymph nodes, as well as the
Peyer’s patches [19]. The stimulation by β-glucans has been shown to have a significant increase in the
production of IL-12, IL-6, and TNF-α [20]. These pro-inflammatory cytokines aid in the production
and proliferation of Th-1, Th-2, NK-cells, B-cells, and the production of immunoglobulins by plasma
cells [21]. Although in most species these pathways support the immune stimulation, it did not
support the same effect in cats. Studies in dogs have shown that both the cell-mediated and humoral
responses of the innate and adaptive immune system were beneficially affected by the introduction of
β-glucans [7,22]. While dogs and cats share similar immunological pathways and mechanisms [23],
there is no clear explanation as to why there was not a similar response in cats.
One clear difference between the immunology of cats and dogs is the presence of the genes
encoding the major histocompatibility complex (MHC). The genetic makeup of dogs’ MHC II, unlike
that of cats, has been shown to have all three of the genes enabling proper antigen presentation. The dog
leukocyte antigen complex (DLA) genes for MHC II are made up of DLA-DP-DQ-DR; in contrast,
the feline leukocyte antigen complex (FLA), which is made up of FLA-DP-DR, shows a severe decrease
in the function of the DP, which may explain an increased susceptibility to autoimmune disorders in
felines [24]. It could be that the already naturally hindered pathway taken from MHC II to the CD4+
cells to eventually induce an antibody response in cats, may be interrupted by the introduction of
β-1,3-1,6-glucans. With the increase of IL-12 and TNFα, β-glucans may cause an epigenetic shift that
favors the production of proinflammatory cytokines as well as natural killer cells, as opposed to other
species showing increases in antibody response. Further research looking at the cytokines produced,
and the level at which they are produced, will help explain what pathways are favored depending on
the presence or absence of β-1,3-1,6-glucans in the diet of cats.
Our knowledge of the intestinal bacterial microbiome of both dogs and cats is evolving rapidly,
and it has been shown that the intestinal microbiome of cats is much more diverse than the microbial
communities in the intestine of dogs [25,26]. The diversity between cats is however smaller than
that of the diversity between dogs. Though both species are carnivores, capable of eating meat and
plants, the narrow food requirements of cats as obligate carnivores require more precision in the
formulation of its diets, relative to the more omnivorous dogs [27]. It was postulated that Saccharomyces
is not an indigenous organism in any species’ intestinal microbiota, but rather, is found only after
nutritional consumption [28]. Saccharomyces species are, however, found in large quantities in the
intestinal microbiome of cats, and this may be an indication as to why the β-1,3-1,6-glucans, derived
from the yeast cell wall of Saccharomyces cerevisiae, have had a different effect compared to what is seen
in other animal species. The supplementation with extra β-glucans, resulting in even higher levels of
β-glucans, might be a reason for why the β-1,3-1,6-glucan supplemented diet had a different effect.
Further investigation of the intestinal microbiome of cats, the effects of Saccharomyces in conjunction
with S. cerevisiae derived β-1,3-1,6-glucan on the gut associated lymphoid tissue, and the overall feline
immune system is needed.
Though this study was not designed to detect the differences between sex, we noticed (though
not significant because of the small sample size) a difference between male and female cats. It is
unclear whether there could be an immunological mechanism, more strongly associated with female
cats, that could cause a rabies antibody suppression after the oral supplementation of β-glucans.
Previous research showed a difference in immunological response to antigens based on sex in other
species [29–33]. There are indications that testosterone, androgen, and estrogen levels in any species
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have immunological regulating capacities [34–36]. Repeating the study with a higher number of
animals may bring clarity in this potential difference.
5. Conclusions
In contrast to other animal species, the β-1,3-1,6-glucan supplemented diet did not give the
same effect on anti-rabies antibodies in cats. While in other animal species, the β-1,3-1,6-glucans
showed significantly higher antibody titers than the non-supplemented feed, in cats, it was the inverse.
The reasons for this remain unclear and need further investigation.
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